Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Appetite For HPV Vaccine Delivers Surprise For Merck

Executive Summary

When Merck realized that demand in China is so large for its HPV vaccine Gardasil, the US company wanted to understand more about the market, but a coordinated pre-launch awareness campaign appears to have helped. 

You may also be interested in...



Gardasil Set For Further Growth As England Okays HPV Vaccine For Boys

The decision to expand the HPV vaccination program in England to boys comes as Merck & Co sees "an unprecedented increase in global demand" for Gardasil.

Shingrix Gets China Nod But Won’t Launch Until 2020 Amid Strong Demand

Following a priority review, Shingrix may become the next hit vaccine in China as millions seek preventative care, but GSK is being cautious over supply plans.

Calm Before The Storm: Pharma Opens 2019 With A Bang In China

Products old, new and reimbursed were the driving force for foreign drug firms including AstraZeneca, Merck and Pfizer and Sanofi to smash growth in China in the first quarter.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

SC123517

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel